Home/Noetik/Ron W. Alfa, MD, PhD

RW

Ron W. Alfa, MD, PhD

Co-Founder, CEO

Therapeutic Areas

Oncology Immuno-oncology

Noetik Pipeline

Drug	Indication	Phase
AI-Enriched Clinical Trials	Oncology	Development
Clinical-Stage Drug Repositioning	Oncology	Pre-clinical/Development
Novel Target Discovery	Cancer Immunotherapy	Discovery

Leadership Team at Noetik

Lacey Padrón, PhD

Chief Technology Officer

Shafique Virani, MD, FRCS

Chief Business Officer

Emily Corse, PhD

Executive Vice President, Therapeutics

Daniel Bear, PhD

Vice President, AI Research

View full Noetik profile